Company / Interest Expense
ADC Therapeutics SA Interest Expense History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$16.3M
FY2025
5-year range
$16.3M / $46.3M
FY2023-FY2025
Trend
-64.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $37M to $16M over the past 2 years.
Based on SEC 10-K filings.
$16M in FY2025.
Improved from $37M to $16M over the past 2 years.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, interest expense decreased 64.9% year-over-year.
Company context
Key Data Points
- Altman Z-Score -4.83 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $16.3M | -64.9% |
| FY2024 | $46.3M | +26.1% |
| FY2023 | $36.7M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026